WeedMD Inc., a federally-licensed producer and distributor of medical-grade cannabis, is plased to announce that its subsidiary Starseed Medicinal Inc. (“Starseed”) is now the preferred supplier of medical cannabis to the IUPAT Province of Ontario Health & Welfare Trust Fund’s participants. The agreement provides approximately 7,000 IUPAT members and their dependents with medical cannabis as an insured benefit, with no co-pay or out-of-pocket costs.
“We are honoured to welcome the IUPAT members to Starseed’s full-service medical platform which is now being sourced from WeedMD’s medical-grade cannabis production platform,” said Angelo Tsebelis, CEO of WeedMD. “Our end-to-end service model eliminates the many barriers associated with traditional ways of accessing cannabis and is transforming how Canadians access medical cannabis. We are pleased to work with progressive partners to continue to legitimize cannabis as an effective treatment option.”
“Providing our members with safe access to a broad and diverse range of medical cannabis therapies to suit their individual health and wellness needs is a positive step forward in sourcing alternatives to traditional pharma therapies,” said Jeffrey C. Baldwin, President – Benefit Plan Administrators (BPA) Limited, the administrator of the International Union of Painters and Allied Trades. “As cannabis industry leaders, Starseed and WeedMD are trusted sources of medical cannabis and we’re proud to partner with them to facilitate safe and affordable access for our members.”
Starseed and WeedMD are focused on delivering premium medical cannabis products through a unique education and service model. Access WeedMD’s investor presentation here.
Investor Relations Service Agreement
WeedMD also announced today that it has engaged KCSA Strategic Communications (“KCSA”), to provide investor relations services effective as of February 24, 2020 (the “Service Agreement”). Pursuant to the Service Agreement, KCSA will provide comprehensive investor relations services for an initial term of six months and unless terminated by either party, will thereafter be automatically renewed on a month-to-month basis. Pursuant to the Service Agreement, WeedMD will pay KCSA a monthly base fee of US$8,000, plus reasonable out-of-pocket expenses. KCSA does not currently own any shares of WeedMD nor does it have any other direct or indirect interest in WeedMD.